Acute Kidney Injury

Communities Weekly Rewind: Bilateral Renal Infarctions

Query
How does a relatively young healthy person suddenly develop bilateral renal infarcts?

Communities Weekly Rewind: IgG1-lambda mesangial proliferative GN

Query
PGNMID is an uncommon diagnosis, and without any evidence of a circulating paraprotein or cell clonality in the bone marrow, what is the pathophysiology of this lesion and how do we go about treating it?

Communities Weekly Rewind: Hope and Innovation in Nephrology

Months of efforts by ASN staff culminated on April 26, 2018, when ASN signed a Memorandum of Understanding with the Department of Health and Human Services to establish the Kidney Innovation Accelerator, KidneyX.

Newly Launched KidneyX Aims to Accelerate the Commercialization of Innovative Therapies in Kidney Care

ASN and the U.S. Department of Health and Human Services (HHS) have sent a clear signal in their desire to have new therapies in the kidney space through the signing of a Memorandum of Understanding establishing the Kidney Innovation Accelerator (KidneyX), a collaborative environment in which a community of researchers, innovators, and investors can participate.

ASN, along with 36 kidney organizations, signed letter to Senate Appropriations for additional kidney research funding at NIH

On Monday, April 23, the American Society of Nephrology and a record-setting coalition of 36 other organizations in the kidney community, authored a letter to the leadership of the House and Senate Appropriations Subcommittees that appropriate funds for the National Institutes of Health (NIH).

Communities Weekly Rewind: Normal Saline vs. Balanced Solution

This Communities discussion compared the results of two randomized clinical trials (SMART and SALT-ed) reported on in the New England Journal of Medicine that compared the effects of normal saline and a “balanced solution” in preventing AKI. Isotonic saline (0.9% NS) is the main crystalloid solution used for resuscitation of hypovolemic critically or non-critically ill patients.

U.S. Opioid Crisis: July Special Section


The July issue of Kidney News features a special section on the US opioid epidemic and the correlation with kidney disease.

 

Interactive Map

Scientists modify CRISPR to epigenetically treat diabetes and kidney disease in mice

"Salk scientists have created a new version of the CRISPR/Cas9 genome editing technology that allows them to activate genes without creating breaks in the DNA, potentially circumventing a major hurdle to using gene editing technologies to treat human diseases.

Physician stress and burnout: The causes and potential solutions for nephrologists

At Kidney Week in New Orleans, I presented a session on the impact of growing stress and burnout in Nephrologists and how it might affect physician attitudes and behaviors toward patient care. The main point of my talk was to recognize how serious an issue physician dissatisfaction, stress, and burnout is, the causes and the barriers, and what can be done to help our physicians (and staff) better adjust to the pressures of today’s health care environment.


Let me explain.

NKF releases results from patient-led survey on kidney disease research priorities

Yesterday, September 28, 2017, the National Kidney Foundation (NKF) published findings from a “year-long outreach and engagement with patients and caregivers to identify patient-led kidney disease research priorities”. The findings “include the research topics that matter most to patients and family members affected by kidney disease; barriers that prevent patients from being active participants in kidney disease research or part of the research team; and what potential solutions may exist”.

Pages